Associated Papers
Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up.
Kim TM et al.
Bmc Cancer, 2020
33287735 (PubMed )
Supplement: 12885_2020_7684_MOESM2_ESM.xlsx › Sheet1
A de novo and novel mutation in the EYA1 gene in a Chinese child with branchio-oto-renal syndrome.
Li G et al.
Intractable & Rare Diseases Research, 2018
Select a paper to view details